Abstract:The goal of this study was to see how effective subcutaneous (SC) insulin is and two different types of oral insulin-loaded nanoparticles (INS) including carboxymethyl chitosan nanoparticles (CMCNPs) and gold nanoparticles (AuNPs) separately and compare their effects on glucokinase, pyruvate kinase gene expressions, and other parameters in diabetes type one male Wistar rats. Seven groups of ten male Wistar rats for each group were formed at random including four control groups (n = 10) and three treatment groups (n = 10). The control groups consisted of four control groups (10 rats for each) and three treatment groups (10 rats for each). Normal control rats were not given any treatment, as were diabetic rats that were not given any treatment, and diabetic rats that were given oral nanoparticles (CMCNPs and AuNPs). Diabetic rats were given subcutaneous insulin, oral insulin-loaded carboxymethyl chitosan nanoparticles (INS-CMCNPs), and oral insulin-loaded gold nanoparticles (INS-AuNPs). The rats were treated for the final 3 weeks of the experiment, which lasted 4 weeks. CMCNPs and AuNPs presented a promising effect on pyruvate kinase and Glucokinase gene expressions compared to subcutaneous insulin. We also discovered that conjugating insulin to CMCNPs and AuNPs protects them from the insulin-degrading enzyme, which offers managed bioavailability. Furthermore, we investigated the effects of CMCNPs and AuNPs on several parameters and discovered that both have a significant effect in vivo, which enables glucose level regulation, and improves patient organ activity for better glucose consumption. PRACTICAL APPLICATIONS: In this paper, we discussed the effect of oral INS-CMCNPs and INS-AuNPs, and compared their effects on Glucokinase and pyruvate kinase gene expressions and other biochemical parameters in diabetes type one male Wistar rats. On the other hand, we investigated the impact of oral INS and subcutaneous insulin separately on the same parameters and their effect on the histology of the liver and pancreas of diabetic rats. According to our research, as we discussed the different mechanisms of INS-CMCNPs and INS-AuNPs, they presented a promising effect compared to SC insulin. They can be used to keep oral insulin safe from the environment of the gastrointestinal system to overcome all the barriers, improve the therapeutic, and clinical outcomes of insulin by maintaining its desired concentration inside the body, ending the panic of the patient from receiving insulin by the SC injection by increasing his satisfaction with receiving accurate oral insulin doses.

Effects of insulin aerosoll on blood glucose by pulmaonary delivery in normal and diabetic rats

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

BIOAVAILABILITIES OF INSULIN AEROSOL BY PULMONARY DELIVERY TO RATS

Comparing The Enhancement Efficiency Between Liposomes And Microbubbles For Insulin Pulmonary Absorption

Multicenter Clinical Study on the Efficacy and Safety of Inhalable Insulin Aerosol in the Treatment of Type 2 Diabetes.

PROPERTIES AND HYPOGLYCEMIC EFFECT OF THE INSULIN-LOADED NANOPARTICLES FOR ORAL ADMINISTRATION

Hypoglycaemic effect of insulin by buccal delivery in normal rats

Artificial Pulmonary Surfactant As A Carrier for Intratracheally Instilled Insulin

Preparation of Insulin-loaded Sodium Alginate Nanoparticles and Its Pharmacodynamics Study on Diabetic Rats

Pharmacodynamic and pharmacokinetic studies of an insulin buccal spray formulation in rats and rabbits

The effect of insulin-loaded gold and carboxymethyl chitosan nanoparticles on gene expression of glucokinase and pyruvate kinase in rats with diabetes type 1

Primary Study on Artificial Pulmonary Surfactant As Carrier of Insulin Pulmonary Delivery

Studies on Administration and Mechanism of Insulin Oily Formulation

Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles

[Study on Preparation and Oral Efficacy of Insulin-Loaded Poly(lactic-Co-glycolic Acid) Nanoparticles].

Hypoglycemic Effect of Intravenous Polyethylene Glycol-Coated Liposomal Insulin on Normal Rats

Investigation of Factors Influencing the Effectiveness of Deformable Nanovesicles for Insulin Nebulization Inhalation

Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats

The current situation and prospect of the research on non-injection preparation of insulin

Effects of Oral Administration of Porcine Insulin on Type 1 Diabetes Prevention and Treatment in Rat

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin